Meagan Kay

Clinical Assistant Professor, Epidemiology



MPVM Preventive Veterinary Medicine, University of California (Davis), 2007
DVM Veterinary Medicine, University of California (Davis), 2006
BS Biology, University of California (San Diego), 2001



401 5th Avenue
Suite 1250
Public Health - Seattle & King County
Seattle, WA 98104


Meagan Kay, DVM, MPVM (she/her) is the Deputy Chief of the Communicable Disease Epidemiology and Immunization Section (CD-Imms) in the Prevention Division of Public Health – Seattle & King County (PHSKC). After practicing clinical veterinary medicine at a 24-hour small animal hospital for several years, Meagan completed the CDC’s Epidemic Intelligence Service (EIS) fellowship at PHSKC during 2009–2011. After EIS, Meagan completed the CDC’s Health Systems Integration Program (HSIP), during which she worked at PHSKC to bridge public health and local health care and support community health needs assessments. In 2013, she rejoined CD-Imms as a medical epidemiologist and became the Section’s Deputy Chief in 2016. She has led or supported the Section’s preparedness and response efforts to a variety of communicable disease outbreaks, including influenza A H1N1, MERS-CoV, Ebola, Zika, hantavirus, measles, mumps, hepatitis A, COVID-19, mpox, foodborne and enteric illnesses, and healthcare-associated infection investigations. She enjoys mentoring students, fellows, and other trainees in applied epidemiology and supporting pathways for future careers in public health practice.

Research Areas

Research Interests

Infectious diseases including zoonotic and emerging diseases
Healthcare-associated infections

Recent Publications (PubMed)

Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study-King County, Washington, May-October 2022.
(2024 Mar)
Open Forum Infect Dis 11(3): ofae029
Karmarkar EN, Golden MR, Kerani RP, Pogosjans S, Chow EJ, Bender Ignacio RA, Ramchandani MS, Kay MK, Cannon CA, Dombrowski JC

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Associated With an Indoor Music Event That Required Proof of Full Vaccination Against Coronavirus Disease 2019 (COVID-19) Prior to Entry-Seattle, July 2021.
(2022 Oct 3)
Clin Infect Dis 75(Suppl 2): S251-S253
Roskosky M, Moni G, Kawakami V, Lambert J, Brostrom-Smith C, Whitney H, Phu A, Look J, Pallickaparambil A, Kay M, Duchin J

Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection - Four States, October 2021-January 2022.
(2022 Apr 8)
MMWR Morb Mortal Wkly Rep 71(14): 524-526
Roskosky M, Borah BF, DeJonge PM, Donovan CV, Blevins LZ, Lafferty AG, Pringle JC, Kelso P, Temte JL, Temte E, Barlow S, Goss M, Uzicanin A, Bateman A, Florek K, Kawakami V, Lewis J, Loughran J, Pogosjans S, Kay M, Duchin J, Lunn S, Schnitzler H, Arora S, Tate J, Ricaldi J, Kirking H

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021.
(2021 Sep 17)
MMWR Morb Mortal Wkly Rep 70(37): 1284-1290
Scobie HM, Johnson AG, Suthar AB, Severson R, Alden NB, Balter S, Bertolino D, Blythe D, Brady S, Cadwell B, Cheng I, Davidson S, Delgadillo J, Devinney K, Duchin J, Duwell M, Fisher R, Fleischauer A, Grant A, Griffin J, Haddix M, Hand J, Hanson M, Hawkins E, Herlihy RK, Hicks L, Holtzman C, Hoskins M, Hyun J, Kaur R, Kay M, Kidrowski H, Kim C, Komatsu K, Kugeler K, Lewis M, Lyons BC, Lyons S, Lynfield R, McCaffrey K, McMullen C, Milroy L, Meyer S, Nolen L, Patel MR, Pogosjans S, Reese HE, Saupe A, Sell J, Sokol T, Sosin D, Stanislawski E, Stevens K, Vest H, White K, Wilson E, MacNeil A, Ritchey MD, Silk BJ

Accuracy of Medical Examiner's Assessment for Near-Real-Time Surveillance of Fatal Drug Overdoses, King County, Washington, March 2017-February 2018.
(2022 May-Jun)
Public Health Rep 137(3): 463-470
Vannice K, Hood J, Yarid N, Kay M, Harruff R, Duchin J

Show complete publication list

In the News

No news articles at this time.